Correlation Between Adial Pharmaceuticals and Andritz AG

Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Andritz AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Andritz AG into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adial Pharmaceuticals and Andritz AG, you can compare the effects of market volatilities on Adial Pharmaceuticals and Andritz AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Andritz AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Andritz AG.

Diversification Opportunities for Adial Pharmaceuticals and Andritz AG

-0.6

Correlation Coefficient

Adial Pharmaceuticals  Andritz AG

Excellent diversification

The 3 months correlation between Adial and Andritz is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Andritz AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Andritz AG and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Andritz AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Andritz AG has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Andritz AG go up and down completely randomly.

Pair Corralation between Adial Pharmaceuticals and Andritz AG

Given the investment horizon of 90 days Adial Pharmaceuticals is expected to generate 1.28 times more return on investment than Andritz AG. However, Adial Pharmaceuticals is 1.28 times more volatile than Andritz AG. It trades about 0.02 of its potential returns per unit of risk. Andritz AG is currently generating about -0.15 per unit of risk. If you would invest  106.00  in Adial Pharmaceuticals on September 21, 2024 and sell it today you would earn a total of  1.00  from holding Adial Pharmaceuticals or generate 0.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Adial Pharmaceuticals  vs.  Andritz AG

Adial Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Adial Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward indicators, Adial Pharmaceuticals is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Andritz AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Andritz AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Adial Pharmaceuticals and Andritz AG

The main advantage of trading using opposite Adial Pharmaceuticals and Andritz AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Andritz AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Andritz AG will offset losses from the drop in Andritz AG's long position.

The idea behind Adial Pharmaceuticals and Andritz AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.